arrow
K

Konstantinos Stellos

Heidelberg University
H指数:55
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiac and vascular involvement in protein misfolding diseases

蛋白质错误折叠疾病中的心脏和血管病变

2026-11-050
PRE
Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index

通过推导和验证升高的甘油三酯-葡萄糖指数来改善心血管风险分层

2025-11-030
OAAI
Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countries

非ST段抬高急性冠状动脉综合征GRACE评分的扩展:一项在十个国家进行的开发和验证研究

2025-10-160
OAAI
How to measure and model cardiovascular aging

Spray, L.; Richardson, G.; Booth, L.K.; Haendeler, J.; Altschmied, J.; Bromage, D.I.; Wallis, S.B.; Stellos, K.; Tual-Chalot, S.; Spyridopoulos, I. 如何测量和建模心血管衰老。Cardiovasc. Res. 2025, 121, 1489–1508. [Google Scholar] [CrossRef]

2025-08-280
OA
Imidazole propionate is a driver and therapeutic target in atherosclerosis

咪唑丙酸是动脉粥样硬化的驱动和治疗靶点

Nature
IF48.5
2025-07-160
OA
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases

心力衰竭基因治疗的现状和前景。ESC心力衰竭协会、ESC心血管基因组学理事会和ESC心肌和心包疾病工作组的科学声明

2024-11-220
PRE
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study

循环淀粉样蛋白 β1-40与他汀类药物治疗和LDL胆固醇降低独立相关: 一项前瞻性队列研究

2024-10-280
PRE
Incremental Value of Blood-Based Markers of Liver Fibrosis in Cardiovascular Risk Stratification
2024-09-110
OA